AP
KRYS icon

Aspect Partners’s Krystal Biotech KRYS Stock Holding History

Aspect Partners’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.72K Buy
+10
New +$2.99K ﹤0.01% 460

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Aspect Partners's KRYS Position: Q2 2026 in Review

Aspect Partners opened a new position in Krystal Biotech (KRYS) in Q2 2026: 10 shares worth $3.72K. The stake represents ﹤0.01% of the portfolio and ranks #460 among its holdings.

74 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Aspect Partners held 10 shares of Krystal Biotech worth $3.72K as of Q2 2026.
  • Krystal Biotech was a new Aspect Partners position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #460 holding.
  • 74 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.